Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 298, Issue 2, 2010, Pages

  Von Hayn, Kathrin ^a   Werthmann, Ruth C ^a   Nikolaev, Viacheslav O ^a   Hommers, Leif G ^a   Lohse, Martin J ^a   Bünemann, Moritz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adenylyl cyclases; cAMP; Fluorescence resonance energy transfer; Purinergic receptors; Vascular smooth muscle cells

Indexed keywords

ADENYLATE CYCLASE; CALCIUM ION; CYCLIC AMP; 8 METHOXYMETHYL 3 ISOBUTYL 1 METHYLXANTHINE; 8-METHOXYMETHYL-3-ISOBUTYL-1-METHYLXANTHINE; ADENYLYL CYCLASE 4; ADENYLYL CYCLASE 6; ADENYLYL CYCLASE TYPE V; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 1; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; ISOENZYME; ISOPRENALINE; PHOSPHODIESTERASE INHIBITOR; PURINERGIC RECEPTOR; URIDINE TRIPHOSPHATE; XANTHINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; FLUORESCENCE RESONANCE ENERGY TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETIC PROCEDURES; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; TIME; VASOCONSTRICTION; VASODILATATION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ANIMALS; AORTA; BIOSENSING TECHNIQUES; CALCIUM SIGNALING; CELLS, CULTURED; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE RESONANCE ENERGY TRANSFER; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; ISOENZYMES; ISOPROTERENOL; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHODIESTERASE INHIBITORS; RECEPTORS, PURINERGIC; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; URIDINE TRIPHOSPHATE; VASOCONSTRICTION; VASODILATION; XANTHINES;

EID: 75749129478     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00197.2009     Document Type: Article

References (41)

1. Abdel-Latif AA. Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp Biol Med (Maywood) 226: 153-63, 2001.
2. Alexander RW, Brock TA, Gimbrone MA, Rittenhouse, SE Jr. Angiotensin increases inositol triphosphate and calcium in vascular smooth muscle. Hypertension 7: 447-451, 1985.
3. 6 receptor in macrophages, endothelial cells and vascular smooth muscle cells. Mol Pharmacol 74: 777-784, 2008.
4. Beazely MA, Watts VJ. Regulatory properties of adenylate cyclases type 5 and 6: A progress report. Eur J Pharmacol 535: 1-12, 2006.
5. Bolton TB. Calcium events in smooth muscles and their interstitial cells; physiological roles of sparks. J Physiol 570: 5-11, 2006.
6. 2+ increase in the inhibition of intracellular cAMP content. Cell Signal 11: 651-663, 1999.
7. 6 receptor. Biochem Biophys Res Commun 222: 303-308, 1996.
8. Conti M, Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76: 481-511, 2007.
9. Cooper DMF. Regulation and organization of adenylyl cyclases and cAMP. Biochem J 375: 517-29, 2003.
10. Cooper DMF. Molecular and cellular requirements for the regulation of adenylate cyclases by calcium. Biochem Soc Trans 31: 912-915, 2003.
11. Cooper DMF, Mons N, Karpen JW. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374: 421-424, 1995.
12. Dyer JL, Liu Y, Pino de la Huerga I, Taylor CW. Long lasting inhibition of adenylyl cyclase selectively mediated by inositol 1,4,5-triphosphate-evoked calcium release. J Biol Chem 280: 8936-8944, 2005.
13. i- specific region. J Biol Chem 280: 24584-24590, 2005.
14. Guillou JL, Nakata H, Cooper DMF. Inhibition by calcium of mammalian adenylyl cyclases. J Biol Chem 274: 35539-35545, 1999.
15. Hanoune J, Defer N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 41: 145-174, 2001.
16. s activation is time-limiting in initiating receptor-mediated signalling. J Biol Chem 281: 33345-33351, 2006.
17. Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN. Comparative pharmacology of human β-adrenergic receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 369: 151-159, 2004.
18. House SJ, Potier M, Bisaillon J, Singer HA, Trebak M. The nonexcitable smooth muscle: Calcium signaling and phenotypic switching during vascular disease. Pflügers Arch 456: 769-785, 2008.
19. Jaggar JH, Porter VA, Lederer WJ. Calcium sparks in smooth muscle. Am J Physiol Cell Physiol 278: C235-C256, 2000.
20. 2+ transients in rat cerebral artery smooth muscle cells. Am J Physiol Heart Circ Physiol 286: H535-H544, 2004.
21. von Kügelen I, Wetter A. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362: 310-323, 2000.
22. Kühbandner S, Brummer S, Metzger D, Chambon P, Hofmann F, Feil R. Temporally controlled somatic mutagenesis in smooth muscle. Genesis 28: 15-22, 2000.
23. 2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line. J Biol Chem 280: 31294-31302, 2005.
24. Linder JU. Class III adenylyl cyclases: molecular mechanisms of catalysis and regulation. Cell Mol Life Sci 63: 1736-1751, 2006.
25. T method. Methods 25: 402-408, 2001.
26. 2+ influx. Mol Pharmacol 54: 122-128, 1998.
27. Nikolaev VO, Bünemann M, Hein L, Hannawacker A, Lohse MJ. Novel Single Chain cAMP Sensors for Receptor-induced Signal Propagation. J Biol Chem 279: 37215-37218, 2004.
28. Omori K, Kotera J. Overview of PDEs and their regulation. Circ Res 100: 309-327, 2007.
29. Ostrom RS, Liu X, Head BP, Gregorian C, Seasholtz TM, Insel PA. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 62: 983-992, 2002.
30. 2+, calmodulin and active cAMP-dependent protein kinase. Pflügers Arch 405: 70-76, 1985.
31. 2+]i in single cells. Prog Clin Biol Res 210: 53-56, 1986.
32. Polson JB, Strada SJ. Cyclic nucleotide phosphodiesterases and vascular smooth muscle (Review). Annu Rev Pharmacol Toxicol 36: 403-427, 1986.
33. Sharma RK, Das SB, Lakshimikuttayamma A, Selvakumar P, Shrivastav A. Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review. Int J Mol Med 18: 95-105, 2006.
34. Sharma RK, Kalra J. Characterization of calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes. Biochem J 299: 97-100, 1994.
35. 2+ transients in human coronary artery smooth muscle cells. Br J Pharmacol 118: 1645-1652, 1996.
36. Stull JT, Gallagher PJ, Herring BP, Kamm KE. Vascular smooth muscle contractile elements. Hypertension 17: 723-732, 1991.
37. Wallach J, Droste M, Kluxen FW, Pfeuffer T, Frank R. Molecular cloning and expression of a novel type V adenylyl cyclase from rabbit myocardium. FEBS Lett 338: 257-263, 1994.
38. Werthmann RC, von Hayn K, Nikolaev VO, Lohse MH, Bünemann M. Real time monitoring of cAMP levels in living endothelial cells: thrombin transiently inhibits adenylyl cyclase 6. J Physiol 587: 4091-4104, 2009.
39. 2+ stimulation of adenylyl cyclase generates dynamic oscillations in cyclic AMP. J Cell Sci 119: 828-836, 2006.
40. 2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol Rev 87: 965-1010, 2007.
41. 2+-inhibitable adenylyl cyclase from NCB-20 cells. Proc Natl Acad Sci USA 89: 6716-6720, 1992.